Marker Therapeutics Stock Pattern Recognition On Neck Pattern

MRKR Stock

USD 1.37 -0.04 -2.84%

This pattern recognition tool runs On Neck Pattern recognition and companion studies for Marker Therapeutics. This view tracks pattern recognition signals tied to momentum and continuation to support structured performance interpretation without implying advice.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The On-Neck Pattern may describe Marker Therapeutics bearish continuation signal.

Marker Therapeutics Technical Analysis Modules

Most technical analysis of Marker Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Marker from various momentum indicators to cycle indicators. When you analyze Marker charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

About Marker Therapeutics Inc

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. The company was founded in 1999 and is headquartered in Houston, Texas. Marker Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. Operational efficiency and capital allocation discipline are central to the long-run profile of Marker Therapeutics. The company is currently operating at a loss. Marker Therapeutics has a market cap of 18.24 M, ROE of -110.67%.

Methodology

Unless otherwise specified, financial data for Marker Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Marker (USA Stocks:MRKR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Marker Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Marker Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Marker Stock is Curated By:

Vlad Skutelnik · Macroaxis Contributor

Learn to be your own money manager

Tracking Marker Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Prophet Now

Portfolio Prophet

Use AI to generate optimal portfolios and find profitable investment opportunities

All Next

Launch Module

Marker Therapeutics pair trading

Pair trading with Marker Therapeutics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Marker Therapeutics Pair Trading

Marker Therapeutics Pair Trading Analysis

Investors who sell Marker Therapeutics at a loss to harvest tax benefits must wait 30 days before repurchasing Marker Therapeutics to avoid the wash-sale disallowance. Holding a correlated substitute during this period minimizes portfolio drift.

A correlation of +1 between Marker Therapeutics and another asset means they move in perfect lockstep, offering no diversification. A correlation of -1 means they move in exactly opposite directions, making the combination with Marker Therapeutics a near-perfect hedge.

Use Correlation analysis and pair trading evaluation for Marker Therapeutics to review hedging context. The context can be applied within sectors, industries, or broader universes.

Pair Correlation Correlation Matching

Additional Tools for Marker Stock Analysis

	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Global Correlations Find global opportunities by holding instruments from different markets
	Equity Valuation Check real value of public entities based on technical and fundamental data
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC